A recent review evaluated the known efficacy and safety of miscellaneous agents that are being studied for the treatment of atopic dermatitis. These agents include targeted topical, oral systemic and biologic agents.
Although limited clinical data exist for many of the agents, the review article notes that several still hold therapeutic promise for ADand continued research is warranted.
Read the review at the Journal of the American Academy of Dermatology. (Requires subscription to view the full article.)
Work Cited:
New therapies for atopic dermatitis: Additional treatment classes, Vakharia, Paras P. et al., Journal of the American Academy of Dermatology, Volume 78, Issue 3, S76 – S83